tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

INDP Stock Latest News

Indaptus Therapeutics reports new data on Phase 1 trial of Decoy20
The FlyIndaptus Therapeutics reports new data on Phase 1 trial of Decoy20
13d ago
INDP
Indaptus Therapeutics initiates Phase 1 study of Decoy20
PremiumThe Fly
Indaptus Therapeutics initiates Phase 1 study of Decoy20
15d ago
INDP
Buy Recommendation for Indaptus Therapeutics: Promising Phase 1 Study and Financial Stability Boost Confidence
PremiumRatings
Buy Recommendation for Indaptus Therapeutics: Promising Phase 1 Study and Financial Stability Boost Confidence
16d ago
INDP
Indaptus Therapeutics reports FY24 EPS ($1.61) vs ($1.83) last year
PremiumThe Fly
Indaptus Therapeutics reports FY24 EPS ($1.61) vs ($1.83) last year
20d ago
INDP
Indaptus Therapeutics expands patent portfolio in China, Japan, Israel
PremiumThe Fly
Indaptus Therapeutics expands patent portfolio in China, Japan, Israel
29d ago
INDP
Indaptus Therapeutics files to sell 10M shares of common stock for holders
PremiumThe FlyIndaptus Therapeutics files to sell 10M shares of common stock for holders
2M ago
INDP
Indaptus Therapeutics files to sell 4.37M shares of common stock for holders
Premium
The Fly
Indaptus Therapeutics files to sell 4.37M shares of common stock for holders
2M ago
INDP
Indaptus receives approval from Health Canada to expand trial of Decoy20
Premium
The Fly
Indaptus receives approval from Health Canada to expand trial of Decoy20
2M ago
INDP
Indaptus Therapeutics announces anticipated milestones in 1H of 2025
PremiumThe Fly
Indaptus Therapeutics announces anticipated milestones in 1H of 2025
3M ago
INDP
Indaptus Therapeutics files to sell 1.94M shares of common stock for holders
PremiumThe Fly
Indaptus Therapeutics files to sell 1.94M shares of common stock for holders
3M ago
INDP
Indaptus to sell 1.82M shares at $1.175 in registered direct offering
PremiumThe Fly
Indaptus to sell 1.82M shares at $1.175 in registered direct offering
4M ago
INDP
Indaptus Therapeutics price target lowered to $5 from $8 at Maxim
PremiumThe Fly
Indaptus Therapeutics price target lowered to $5 from $8 at Maxim
5M ago
INDP
Indaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last year
PremiumThe FlyIndaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last year
5M ago
INDP
Indaptus Therapeutics sees cash runway into 1Q25
Premium
The Fly
Indaptus Therapeutics sees cash runway into 1Q25
5M ago
INDP
Indaptus Therapeutics publishes research in Frontiers in Immunology
Premium
The Fly
Indaptus Therapeutics publishes research in Frontiers in Immunology
5M ago
INDP
Indaptus Therapeutics completes safety, PK, biomarker data on Decoy20
PremiumThe Fly
Indaptus Therapeutics completes safety, PK, biomarker data on Decoy20
5M ago
INDP
Indaptus Therapeutics announces clinical supply agreement with BeiGene
PremiumThe Fly
Indaptus Therapeutics announces clinical supply agreement with BeiGene
5M ago
BGNE
INDP
Indaptus initiates unrestricted enrollment on patients on Decoy20 weekly dosing
PremiumThe Fly
Indaptus initiates unrestricted enrollment on patients on Decoy20 weekly dosing
6M ago
INDP
Indaptus Therapeutics CSO to speak on webinar about cancer immunotherapy
PremiumThe Fly
Indaptus Therapeutics CSO to speak on webinar about cancer immunotherapy
6M ago
INDP
Indaptus Therapeutics files to sell 1.64M shares of common stock for holders
PremiumThe FlyIndaptus Therapeutics files to sell 1.64M shares of common stock for holders
7M ago
INDP
Indaptus Therapeutics to initiate dosing of patients at higher Decoy20 dose
Premium
The Fly
Indaptus Therapeutics to initiate dosing of patients at higher Decoy20 dose
7M ago
INDP
Indaptus Therapeutics sees cash runway into 1Q25
Premium
The Fly
Indaptus Therapeutics sees cash runway into 1Q25
8M ago
INDP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >